OOIR: Observatory of International Research

Papers

(The TQCC of Transfusion Medicine is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Convalescent plasma therapy for the treatment of patients with COVID‐19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels	52
Impact of COVID‐19 in the attendance of blood donors and production on a Brazilian Blood Centres	18
Clinical Implication of Immunohaematological Tests in ABO haemolytic disease of newborn: Revisiting an old disease	15
Effect of convalescent plasma as complementary treatment in patients with moderate COVID‐19 infection	14
Comparison of four methods to measure haemoglobin concentrations in whole blood donors (COMPARE): A diagnostic accuracy study	13
Practical approach to transfusion management of post‐partum haemorrhage	12
Impact of severe acute respiratory syndrome on blood services and blood in Hong Kong in 2003	11
Absence of SARS‐CoV‐2 viraemia in a blood donor with COVID‐19 post‐donation	11
Erythropoiesis‐stimulating agents as replacement therapy for blood transfusions in critically ill patients with anaemia: A systematic review with meta‐analysis	11
Machine learning for predicting preoperative red blood cell demand	11
Convalescent plasma for COVID‐19: Back to the future	11
Systematic review and meta‐analysis of randomised controlled trials testing the safety and efficacy of convalescent plasma in the treatment of coronavirus disease 2019 (COVID‐19): Evidence‐	10
Motivators of and barriers to becoming a COVID‐19 convalescent plasma donor: A survey study	10
Effect of leukoreduction on transfusion‐related immunomodulation in patients undergoing cardiac surgery	10
Hydrops fetalis associated with anti‐CD36 antibodies in fetal and neonatal alloimmune thrombocytopenia: Possible underlying mechanism	10
Trust and distrust: Identifying recruitment targets for ethnic minority blood donors	10
Behaviour based screening questions and potential donation loss using the “for the assessment of individualised risk” screening criteria: A Canadian perspective	9
Massive transfusion protocols in paediatric trauma population: A systematic review	9
Adherence to blood product transfusion guidelines—An observational study of the current transfusion practice in a medical intensive care unit	9
Inter‐donor variability in deformability of red blood cells in blood units	8
Evaluating the risk of transfusion and transplant‐transmitted monkeypox infections	8
Risk of hepatitis‐E virus infections among blood donors in a regional blood transfusion centre in western India	8
The Norwegian experience with nationwide implementation of fetal RHD genotyping and targeted routine antenatal anti‐D prophylaxis	7
E‐learning/online education in transfusion medicine: A cross‐sectional international survey	7
Genomic analysis of blood samples with serologic ABO discrepancy identifies 12 novel alleles in a Chinese Han population	7

Convalescent plasma and COVID‐19: Time for a second—second look?	7
Effect of the first year of COVID‐19 pandemic on the collection and use of blood components in Colombia monitored through the national haemovigilance system	7
Safety and efficacy of COVID‐19 convalescent plasma in severe pulmonary disease: A report of 17 patients	7
Beyond COVID‐19 and lessons learned in the United States	7
A review of whole‐blood donors' willingness, motives, barriers and interventions related to donating another substance of human origin	7
Deterrents in recruitment of COVID‐19 convalescent plasma donors: Experience from a hospital‐based blood centre in India	7
Fertility and pregnancy in Iranian thalassemia patients: An update on transfusion complications	6
Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction	6
A UK national survey of prophylactic platelet transfusion thresholds in non‐bleeding, critically ill adults	6
Association between the length of storage of transfused leukoreduced red blood cell units and hospital‐acquired infections in critically ill children: A secondary analysis of the TRIPICU st	6
Development and validation of a nomogram to predict intraoperative blood transfusion for gastric cancer surgery	6
Transfusion in critical care: Past, present and future	6
Effect of patient blood management system and feedback programme on appropriateness of transfusion: An experience of Asia's first Bloodless Medicine Center on a hospital basis	6
Pulmonary complications of transfusion: Changes, challenges, and future directions	6
Monitoring iron stores in Icelandic blood donors from 1997 through 2019	5
Assessment the knowledge of blood transfusion in Iranian nurses of Tehran's hospitals	5
Importation of plasma and use of apheresis platelets as risk reduction measures for variant Creutzfeldt‐Jakob disease: The SaBTO review	5
Extended red blood cell matching for all transfusion recipients is feasible	5
Salvage of refractory post‐transfusion hyperhaemolysis by targeting hyperinflammation and macrophage activation with tocilizumab	5
Comparison of ABO antibody titration, IgG subclasses and qualitative haemolysin test to reduce the risk of passive haemolysis associated with platelet transfusion	5
Alloimmunisation rate of patients on Daratumumab: A retrospective cohort study of patients in England	5
Mapping anticipated advantages and disadvantages of implementation of extensive donor genotyping: A focus group approach	5
Prophylactic tranexamic acid use in non‐cardiac surgeries at high risk for transfusion	5
Transfusion therapy of neonatal and paediatric patients: They are not just little adults	5
Impact of Covid‐19 epidemic on the activities of a blood centre, transfusion support for infected patients and clinical outcomes	4
Skin flora and bacterial contamination of diversion pouch and recovered platelet components in Moroccan blood donors	4
Histo‐blood group A is a risk factor for severe COVID‐19	4
Transfusion 2024: A 5‐year plan for clinical and laboratory transfusion in England	4
ABO‐incompatible convalescent plasma transfusion: Yes, you can	4
Role of ABO blood system in COVID‐19: Findings from a southern Italian study	4
Improving blood‐prescribing decisions: Evaluating the efficacy of a blood guidelines app	4
The haemoglobinopathy survey: The reality of transfusion practice in sickle cell disease and thalassaemia in England	4
Comparative analysis of hepatitis B virus infections in blood donors born before and after the implementation of universal HBV vaccination in southern China	4
Recovery of platelet‐rich red blood cells and acquisition of convalescent plasma with a novel gravity‐driven blood separation device	4
Red blood cell transfusion in myelodysplastic syndromes: A systematic review	4
Probable cefepime‐induced immune mediated hemolytic anaemia	4
Passenger lymphocyte syndrome with severe haemolysis misdiagnosed/treated as cold agglutinin syndrome: Analysis of case and diagnostic error	4
Convalescent plasma for COVID‐19: Donor demographic factors associated high neutralising antibody titres	4
Sickle cell disease patients in two London trusts: Genotyping including RH variants	4
Screening of at‐risk blood donors for Chagas disease in non‐endemic countries: Lessons from a 2‐year experience in Tuscany, Italy	3
Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk‐stratify patients for alloimmunisation risk	3
Pain control and functional improvement in patients treated by autologous conditioned serum after failure of platelet rich plasma treatments in knee osteoarthritis	3
Confirmed non‐invasive prenatal testing for foetal Rh blood group genotyping along with bi‐allelic short insertion/deletion polymorphisms as a positive internal control	3
Blood group P1 prediction using multiplex PCR genotyping of A4GALT among Thai blood donors	3
Impact of microbial contamination of haematopoietic stem cells on post‐transplant outcomes: A retrospective study from tertiary care centre in India	3
Kinetics of anti‐SARS‐COV2 spike protein IgG and IgA antibodies at 4°C: Implications for convalescent plasma stability	3
The lack of anti‐PF4 antibodies in convalescent plasma from COVID‐19 infected blood donor	3
Utility of pre‐operative haemoglobin concentration to guide peri‐operative blood tests for hip and knee arthroplasty: A decision curve analysis	3
Prospective audit of blood transfusion request forms and continuing medical education to optimise compliance of clinicians in a hospital setting	3
London 2017: Lessons learned in transfusion emergency planning	3

A physiology‐based trigger score to guide perioperative transfusion of allogeneic red blood cells: A multicentre randomised controlled trial	3
Emergency response to COVID‐19 epidemic: One Chinese blood centre's experience	3
Quantitative increases of extracellular vesicles in prolonged cold storage of platelets increases the potential to enhance fibrin clot formation	3
Transfusion requirement prediction score for patients undergoing cardiac surgery: An experience from a tertiary care set‐up from South India	3
Patterns of paediatric massive blood transfusion protocol use in trauma and non‐trauma patients	3
Poster session	3
Detection frequencies and viral load distribution of parvovirus B19 DNA in blood and plasma donations in England	3
The use of prothrombin complex concentrate in chronic liver disease: A review of the literature	3
Detection and analysis of blood donors seropositive for syphilis	2
Validation of an apoptosis assay for extracorporeal photopheresis	2
Effects of cryopreservation on gram‐positive bacteria contaminants in umbilical cord blood	2
A survey of nurses to assess transfusion practice at the bedside using an electronic identification system: Experience at a university hospital	2
Efficacy of octreotide in the treatment of gastrointestinal angiodysplasia in a patient with Glanzmann thrombasthenia	2
Motivations for blood donation by HIV‐positive individuals on antiretrovirals in South Africa: A qualitative study	2
Diagnostic accuracy of Abbott Architect Assay as a screening tool for human T‐cell leukaemia virus type‐1 and type‐2 infection in a London teaching hospital with a large solid organ transplant centre	2
A prospective interventional study to assess the impact of a ‘structured compact training’ on knowledge and skills of safe blood transfusion practices among nurses working in a tertiary care institute	2
Divergence in phenotyping and genotyping analysis of the Lewis histo‐blood group system	2
Prevalence of leucocyte antibodies in non‐transfused male and female platelet apheresis donors	2
Blood collection failures from a blood establishment perspective	2
Parvovirus B19 and recipient safety: is it time to do more?	2
Life in times of COVID‐19	2
The contribution and potential of older blood donors in Asia Pacific regions	2
Implementation of an anaemia walk‐in clinic: Feasibility and preliminary data from the Orthopedic University Hospital	2
Role of donor self‐reporting in securing blood safety during COVID‐19 pandemic	2
Demographic, clinical, and biochemical predictors of pica in high‐intensity blood donors	2
Low‐titer group O whole blood in military ground ambulances: Lessons from the Israel Defense Forces initial experience	2
Splanchnic‐cerebral oxygenation ratio associated with packed red blood cell transfusion in preterm infants	2
Higher levels of von Willebrand factor in hospitalised patient plasma provides an explanation for the association of ABO blood group and secretor status with COVID19 severity	2
Impact of the use of hydroxyethyl starch in granulocyte apheresis using Spectra Optia	2
Anaphylactic reaction after pre‐deposit autologous blood transfusion	2
The central blood volume as measured by thoracic electrical impedance and plasma proANP is not compromised by donation of 900 mL of blood in men	2
Hepatitis C virus screening reactive among blood donors in mainland China: A systematic review and meta‐analysis	2
HLA‐DRB1 and cytokine polymorphisms in Brazilian patients with myelodysplastic syndromes and its association with red blood cell alloimmunization	2
Effects of storage on quality and function of acid‐treated platelets with reduced HLA Class I surface expression	2
Randomised controlled trial of glucose‐6‐phosphate dehydrogenase deficient versus non‐deficient red blood cell transfusion in patients with hypoproliferative anaemia	2
A case of hyperhaemolysis syndrome in a pregnant Chinese woman with β‐thalassemia during perinatal transfusion	2
Paroxysmal cold hemoglobinuria: A diagnostic dilemma in a paediatric patient	2
D variants in the population of D‐negative blood donors in the north‐eastern region of Croatia	2
Re‐examine the transfusion transmitted risk of SARS‐CoV‐2 virus during a major COVID‐19 outbreak in 2022	2
ABO(H) and Lewis blood group substances and disease treatment	2
Anti‐HBc and hepatitis B virus DNA among HBsAg‐negative blood donors from the main central blood bank units in Eastern Libya	2
BGvar: A comprehensive resource for blood group immunogenetics	2
Prevalence of anaemia in patients discharged from the paediatric intensive care unit	2
Serological screening and genetic analysis ofRhCEvariants in the Chinese Southern Han donors	2